202 related articles for article (PubMed ID: 21246408)
41. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches.
Locatelli F; Moretta F; Rutella S
Curr Opin Oncol; 2013 Nov; 25(6):707-15. PubMed ID: 24076579
[TBL] [Abstract][Full Text] [Related]
42. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
[TBL] [Abstract][Full Text] [Related]
43. High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia.
Cruz-Rodriguez N; Combita AL; Enciso LJ; Quijano SM; Pinzon PL; Lozano OC; Castillo JS; Li L; Bareño J; Cardozo C; Solano J; Herrera MV; Cudris J; Zabaleta J
J Exp Clin Cancer Res; 2016 Apr; 35():64. PubMed ID: 27044543
[TBL] [Abstract][Full Text] [Related]
44. Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy.
Tao HF; Liu YS; Fang JL; Su YZ; Chen FH; Zhou LY; Zhu YS
Genet Mol Res; 2014 Mar; 13(1):2020-31. PubMed ID: 24737427
[TBL] [Abstract][Full Text] [Related]
45. Personalized care of pediatric cancer patients.
Rabin K; Man TK; Lau CC
Nestle Nutr Workshop Ser Pediatr Program; 2008; 62():173-85; discussion 185-8. PubMed ID: 18626200
[TBL] [Abstract][Full Text] [Related]
46. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
47. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
Chow YP; Alias H; Jamal R
BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
[TBL] [Abstract][Full Text] [Related]
48. Substance P--a potent risk factor in childhood lymphoblastic leukaemia.
Nowicki M; Miśkowiak B
Leukemia; 2003 Jun; 17(6):1096-9. PubMed ID: 12764374
[TBL] [Abstract][Full Text] [Related]
49. Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress.
Goto H
Pediatr Int; 2015 Dec; 57(6):1059-66. PubMed ID: 26455582
[TBL] [Abstract][Full Text] [Related]
50. Gene expression profiling: a possible tool in the prediction of outcome in paediatric acute lymphoblastic leukaemia?
Lanciotti M; D'Apolito M; Paolucci P; Indaco S; Dufour C
Br J Haematol; 2011 Apr; 153(2):279-82. PubMed ID: 21275956
[No Abstract] [Full Text] [Related]
51. Recent research advances in childhood acute lymphoblastic leukemia.
Pui CH
J Formos Med Assoc; 2010 Nov; 109(11):777-87. PubMed ID: 21126650
[TBL] [Abstract][Full Text] [Related]
52. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
Klumper E; Pieters R; Veerman AJ; Huismans DR; Loonen AH; Hählen K; Kaspers GJ; van Wering ER; Hartmann R; Henze G
Blood; 1995 Nov; 86(10):3861-8. PubMed ID: 7579354
[TBL] [Abstract][Full Text] [Related]
53. Management strategies in acute lymphoblastic leukemia.
Rabin KR; Poplack DG
Oncology (Williston Park); 2011 Apr; 25(4):328-35. PubMed ID: 21618954
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.
Ceppi F; Cazzaniga G; Colombini A; Biondi A; Conter V
Expert Rev Hematol; 2015 Feb; 8(1):57-70. PubMed ID: 25367188
[TBL] [Abstract][Full Text] [Related]
55. Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.
Xu H; Shu Y
Methods Mol Biol; 2018; 1754():387-413. PubMed ID: 29536454
[TBL] [Abstract][Full Text] [Related]
56. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.
Wolach O; Amitai I; DeAngelo DJ
Br J Haematol; 2017 Dec; 179(5):705-723. PubMed ID: 29076138
[TBL] [Abstract][Full Text] [Related]
57. Classifying subtypes of acute lymphoblastic leukemia using silhouette statistics and genetic algorithms.
Lin TC; Liu RS; Chao YT; Chen SY
Gene; 2013 Apr; 518(1):159-63. PubMed ID: 23237780
[TBL] [Abstract][Full Text] [Related]
58. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
Holleman A; Cheok MH; den Boer ML; Yang W; Veerman AJ; Kazemier KM; Pei D; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
N Engl J Med; 2004 Aug; 351(6):533-42. PubMed ID: 15295046
[TBL] [Abstract][Full Text] [Related]
59. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
Yeoh EJ; Ross ME; Shurtleff SA; Williams WK; Patel D; Mahfouz R; Behm FG; Raimondi SC; Relling MV; Patel A; Cheng C; Campana D; Wilkins D; Zhou X; Li J; Liu H; Pui CH; Evans WE; Naeve C; Wong L; Downing JR
Cancer Cell; 2002 Mar; 1(2):133-43. PubMed ID: 12086872
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
Ebinger S; Özdemir EZ; Ziegenhain C; Tiedt S; Castro Alves C; Grunert M; Dworzak M; Lutz C; Turati VA; Enver T; Horny HP; Sotlar K; Parekh S; Spiekermann K; Hiddemann W; Schepers A; Polzer B; Kirsch S; Hoffmann M; Knapp B; Hasenauer J; Pfeifer H; Panzer-Grümayer R; Enard W; Gires O; Jeremias I
Cancer Cell; 2016 Dec; 30(6):849-862. PubMed ID: 27916615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
